Sandra Levy
ARTICLES BY THIS AUTHOR
- 6/19/2024
Alembic secures FDA approval for generic Pradaxa
Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in certain instances. - 6/19/2024
Nestlé Health Science to acquire Vowst from Seres
Nestlé Health Science will have full control over the further development, commercialization and manufacturing of Vowst in the U.S. and worldwide. - 6/17/2024
Cranbury Pharmaceuticals receives FDA nod for generic Emflaza
Deflazacort oral suspension is indicated to treat patients five years of age and older for Duchenne muscular dystrophy. - 6/17/2024
Cipla receives FDA OK for generic Somatuline Depot
Cipla’s lanreotide injection is indicated for the treatment of patients with acromegaly and gastroenteropancreatic neuroendocrine tumors. - 6/17/2024
Lupin taps Abdelaziz Toumi as CEO of API CDMO subsidiary
Toumi brings more than two decades of experience in the biotech, pharma and CDMO sectors, spanning Europe, North America and Asia. - 6/17/2024
IQVIA report sizes up global oncology market
Global spending on cancer medicine increased to $223 billion in 2023, $25 billion more than in 2022, and is projected to reach $409 billion by 2028. - 6/17/2024
CVS Media Exchange partners with The Trade Desk
Advertiser partners will have more ways to reach CVS ExtraCare shoppers across off-site channels including programmatic display and connected TV. - 6/16/2024
Moderna receives FDA nod for RSV vaccine mRESVIA
mRESVIA is Moderna’s second approved product and the only RSV vaccine available in single-dose pre-filled syringes. - 6/16/2024
Scripta Insights names David Kershaw as chief technology officer
As CTO, Kershaw will drive the company's technological strategies and lead the engineering and IT teams. - 6/16/2024
Alembic obtains FDA nod for generic Firazyr
Generic Firazyr is used for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.
